Dupilumab in moderate‐to‐severe prurigo nodularis: Real‐world data from early access program
Year: 2026
Type: article
Abstract: Qualified researchers may request access to patient-level data and related documents. The early access program (EAP) Protocol and the summary of the EAP report are available on the Healthcare authority website (https://www.has-sante.fr/). Patient-level data will be anonymized to protect the privacy of the EAP participants.
DOI: 10.1111/jdv.70294
Authors: Marie Jachiet, Clémentine Toussaint, Valérie Dorizy‐Vuong, Sophie Osdoit, Pierre‐André Becherel, Emmanuelle Amazan, Julia Vanlerberghe, Mahtab Samimi, Claudia Soares Barbosa, Carine Vera, Simmi Wiggins, Véronique Marcadé Fulcrand, Cédric Meyer, Laurent Misery, Jean‐David Bouaziz
Institutions: Université Paris Cité, Assistance Publique – Hôpitaux de Paris, Hôpital Saint-Louis, Centre Hospitalier Universitaire de Bordeaux, Centre Hospitalier Saint-Nazaire, Centre Hospitalier Universitaire de Martinique, Centre Hospitalier Universitaire de Lille, Centre Hospitalier Universitaire de Tours, Sanofi (France), Sanofi (United Kingdom), Centre Hospitalier Régional Universitaire de Brest
Language: English
Subfield: Dermatology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $5,450
OpenAlex ID: W7118943462